Xenon Pharmaceuticals Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XENE Nasdaq 2830 www.xenon-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xenon Pharmaceuticals Inc.

Companies Like Xenon Pharmaceuticals (NASDAQ:XENE) Are In A Position To Invest In Growth - Jan 17th, 2026 5:24 am
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 16th, 2026 2:05 pm
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - Jan 12th, 2026 6:30 am
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2026 6:30 am
Is Xenon Pharmaceuticals (XENE) Quietly Reframing Its Epilepsy Bet Through Equity Awards and New Data? - Dec 7th, 2025 5:08 pm
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - Dec 5th, 2025 7:00 am
Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue? - Dec 4th, 2025 9:30 am
Why Is Xenon Pharmaceuticals (XENE) Up 9.7% Since Last Earnings Report? - Dec 3rd, 2025 9:30 am
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 - Dec 3rd, 2025 6:30 am
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 - Nov 25th, 2025 6:30 am
Xenon to Present at Upcoming Investor Conferences - Nov 6th, 2025 6:30 am
Xenon Pharmaceuticals (XENE): Losses Widen 37% Annually, Challenging Bullish Revenue Growth Expectations - Nov 4th, 2025 11:13 pm
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - Nov 4th, 2025 7:54 am
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ... - Nov 3rd, 2025 10:01 pm
Xenon Pharmaceuticals: Q3 Earnings Snapshot - Nov 3rd, 2025 2:32 pm
Xenon Reports Third Quarter 2025 Financial Results & Business Update - Nov 3rd, 2025 2:01 pm
Xenon to Report Q3 2025 Financial Results on November 3, 2025 - Oct 27th, 2025 6:30 am
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer - Oct 16th, 2025 6:30 am
Xenon Pharmaceuticals (XENE): Exploring Valuation After Recent Share Price Momentum - Oct 12th, 2025 4:09 am
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Amid Tech, AI Strength - Oct 2nd, 2025 6:58 am